Axtria Showcases AI-Powered Innovations at PMSA 2024 Fall Symposium USA - English India - English
illi News/10280618

Trending...
CHICAGO, Oct. 8, 2024 ~ Chicago, IL - Axtria Inc., a global leader in cloud software and data analytics for the life sciences industry, showcased its leadership in driving innovative solutions for pharmaceutical companies at the PMSA 2024 Fall Symposium. The two-day summit, held on October 3-4, 2024, brought together industry leaders, researchers, and academics to explore the transformative impact of AI in healthcare.

During the conference, Axtria received several awards for its thought leadership presentations and participated as a gold sponsor, reaffirming its commitment to exchanging knowledge and enhancing the impact of AI in the pharmaceutical industry.

Sudip Chakraborty, Principal and Head of AI/GenAI at Axtria, stated that "At Axtria, we believe that AI is not just a tool but a transformative force that can reshape the pharmaceutical landscape." He also emphasized their dedication to partnering with industry leaders to harness AI-driven insights and solutions that improve decision-making, optimize field operations, and ultimately enhance patient outcomes.

More on illi News
Axtria's experts collaborated with client partners to lead insightful presentations and discussions on advanced AI-driven solutions and strategies tailored for the pharmaceutical industry. Some of these sessions included:

- A case study presented by Axtria and Gilead Sciences on "Nuances of Leveraging Generative AI for Structured Data Processing and Insights." This highlighted the importance of empowering non-technical users to access insights through natural language generation-based applications. These GenAI-powered tools provide intuitive user interfaces with robust data access controls, enabling broader access to critical insights.

- A collaboration between Axtria and Astellas Pharma on "AI-Enabled Action Alerts to Enhance Field Effectiveness." This session demonstrated how AI-powered recommendations are transforming field operations by providing representatives with actionable insights to optimize their engagements, increase prescription uptake (Rx), and enhance overall brand performance. It showcased how Astellas and Axtria worked together to leverage data, convert it into useful rep suggestions, and ultimately improve brand performance through better field execution.

More on illi News
- A discussion with Bayer on "Utilizing AI to Identify Unrealized Opportunities and Optimize End-to-End Field Force Operations." This session explored Bayer's AI-driven transformation of field force operations across design, planning, execution, and talent management. It showcased the tangible business impact of AI.

- A workshop led by Axtria on "Enabling EDA Automation for Commercial Analytics using LLM." This demonstrated how generative AI can automate exploratory data analysis (EDA) processes, transforming raw data into actionable insights. Additionally, Axtria also conducted a focus session on "Accelerating Pharma Business Analytics with AI-Ready Data Products Strategy," where they shared how AI-ready data products can streamline data management, unify fragmented data landscapes, and accelerate analytics while reducing operational costs.

Axtria's participation in the PMSA 2024 Fall Symposium highlighted their commitment to driving innovation in the pharmaceutical industry through the use of AI. Their thought leadership presentations and collaborations with client partners showcased their expertise in harnessing the power of AI to improve decision-making and enhance overall business performance.
Filed Under: Business
Show All News | Report Violation

0 Comments

Latest on illi News